Englewood Health laboratory

Open Clinical Trials

Englewood Health laboratory

Englewood Hospital’s physician-investigators are currently recruiting research subjects for participation in several clinical trials across various departments.

Cardiology

ACURATE IDE: Transcatheter Replacement of Stenotic Aortic Valve through Implantation of ACURATE in Subjects InDicatEd for TAVR

Principal Investigator: Joseph De Gregorio, MD
Coordinator: Joseph Valeri
Phone: 201-894-4283
NCT #: 03735667
Englewood Health IRB #: E-21-860
More Information (clinicaltrials.gov)

Champion AF: WATCHMAN FLX versus NOAC for Embolic Protection in the Management of Patients with Non-Valvular Atrial Fibrillation

Principal Investigator: Grant Simons, MD
Coordinator: Delcia Fuentes
Phone: 201-608-2234
NCT #: 04394546
Englewood Health IRB #: E-20-839
More Information (clinicaltrials.gov)

Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women (ROMA:Women)

Principal Investigator: Molly Schultheis, MD
Coordinator: Joseph Valeri
Phone: 201-894-4283
NCT #: 04124120
Englewood Health IRB #: E-23-928
More Information (clinicaltrials.gov)


Gastroenterology / C Diff

Fecal Microbiota Transplantation (FMT) for the Treatment of Recurrent or Refractory Clostridium Difficile Infection (CDI)

Principal Investigator: Marc Fiorillo, MD
Coordinator: Delcia Fuentes
Phone: 201-608-2234
NCT #: 01942447
Englewood Health IRB #: E-13-507
More Information (clinicaltrials.gov)


Gynecology

A randomized controlled trial to evaluate the efficacy of acupuncture versus aromatherapy as treatments to lessen nausea and vomiting associated with Adriamycin and Cytoxan

Principal Investigator: Tracy Scheller, MD
Coordinator: Nathalia Clark
Phone: 201-894-3088
NCT #: 04116697
Englewood Health IRB #: E-19-773
More Information (clinicaltrials.gov)


Neurological Surgery

A Multicenter Observational Study of GammaTile™ Surgically Targeted Radiation Therapy (STaRT) in Intracranial Brain Neoplasms

Principal Investigator: Kevin Yao, MD
Coordinator: Nathalia Clark
Phone: 201-894-3088
NCT #: 04427384
Englewood Health IRB #: E-21-856
More Information (clinicaltrials.gov)

A Prospective, Concurrently Controlled, Multi-Center Study to Evaluate the Safety and Effectiveness of the Spinal Kinetics M6-C™ Artificial Cervical Disc Compared to Anterior Cervical Discectomy and Fusion (ACDF) for the Treatment of Contiguous Two-Level Symptomatic Cervical Radiculopathy

Principal Investigator: Yakov Gologorsky, MD
Coordinator: Delcia Fuentes
Phone: 201-608-2234
NCT #: 04982835
Englewood Health IRB #: E-22-906
More Information (clinicaltrials.gov)


Oncology

A021806: A Phase III Trial of Periperative vs. Adjuvant chemotherapy for Resectable Pancreatic Cancer

Principal Investigator: Minaxi Jhawer, MD
Coordinator: Hauwa Adeniji
Phone: 201-608-2846
NCT #: 04340141
Englewood Health IRB #: E-21-848
More Information (clinicaltrials.gov)

A Multicenter, Double-blind, Randomized Phase 3 Study to Compare the Efficacy and Safety of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab, in the Adjuvant Treatment of Clear Cell Renal Cell Carcinoma (ccRCC) Post Nephrectomy (MK-6482-022)

Principal Investigator: Brian Kim, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 05239728
Englewood Health IRB #: E-22-880
More Information (clinicaltrials.gov)

A Phase IB/II Multi-Cohort Study of Targeted Agents with Atezolizumab for Patients with Recurrent or Persistent Endometrial Cancer [EndoMAP]

Principal Investigator: Nimesh Nagarsheth, MD
Coordinator: Hauwa Adeniji
Phone: 201-608-2846
NCT #: 04486352
Englewood Health IRB #: E-21-868
More Information (clinicaltrials.gov)

A Phase II/III randomized study of R-miniCHOP with or without CC-486 (oral azacitidine) in patients age 75 years or older with newly diagnosed diffuse large B cell lymphoma, Grade IIIb Follicular Lymphoma, transformed lymphoma, and high-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements [S1918]

Principal Investigator: Adam Zayac, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 04799275
Englewood Health IRB #: E-21-873
More Information (clinicaltrials.gov)

Comparing Olanzapine and Mirtazapine in the Improvement of Unintentional Weight Loss for Patients With Advanced Stage Cancer

Principal Investigator: Vinnidhy Dave, DO
Coordinator: Nathalia Clark
Phone: 201-894-3088
NCT #: 05170919
Englewood Health IRB #: E-21-862
More Information (clinicaltrials.gov)


Oncology / Bladder Cancer

A phase II study of dose-dense gemcitabine plus cisplatin (ddGC) in patients with muscle-invasive bladder cancer with bladder preservation for those patients whose tumors harbor deleterios DNA damage response (DDR) gene alterations

Principal Investigator: Brian Kim, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 03609216
Englewood Health IRB #: E-18-748
More Information (clinicaltrials.gov)


Oncology / Breast Cancer

A011801: The COMPASSHER2 Trials (COMprehensive Use of Pathologic Response ASSessment to Optimize Therapy in HER2-Positive Breast Cancer): COMPASSHER2 Residual Disease (RD), A Double-Blinded, Phase III Randomized Trial of T-DM1 and Placebo Compared with T-DM1 and Tucatinib

Principal Investigator: Jill Morrison, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 04457596
Englewood Health IRB #: E-21-850
More Information (clinicaltrials.gov)


Oncology / Colon Cancer

A021703: Randomized Double-Blind Phase III Trial of Vitamin D3 Supplementation in Patients with Previously Untreated Metastatic Colorectal Cancer (SOLARIS)

Principal Investigator: Minaxi Jhawer, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 04094688
Englewood Health IRB #: E-19-792
More Information (clinicaltrials.gov)


Oncology / Gastric Cancer

IMIGASTRIC II: Prospective, observational, multicenter study on minimally invasive gastrectomy for gastric cancer: robotic, laparoscopic and open surgery compared on operative and follow-up outcomes

Principal Investigator: Steven Brower, MD
Coordinator: Nathalia Clark
Phone: 201-894-3088
NCT #: 02751086
Englewood Health IRB #: E-16-673
More Information (clinicaltrials.gov)


Oncology / Gynecology

A Phase II, Single-Arm Study of Giredestrant in Participants With Grade 1 Endometrial Cancer

Principal Investigator: Nimesh Nagarsheth, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 05634499
Englewood Health IRB #: E-22-913
More Information (clinicaltrials.gov)


Vascular Surgery

A Post-Market, Multi-Center, Prospective, Interventional Study using the Venclose™ System and Venclose MAVEN™ System for Treatment of Chronic Venous Insufficiency of the Great and Small Saphenous Veins and Incompetent Perforator Veins

Principal Investigator: Steven Elias, MD
Coordinator: Joseph Valeri
Phone: 201-894-4283
NCT #: 05504070
Englewood Health IRB #: E-22-910
More Information (clinicaltrials.gov)

Evaluation of the GORE® VIAFORT Vascular Stent for Treatment of Symptomatic Iliofemoral Venous Obstruction

Principal Investigator: Steven Elias, MD
Coordinator: Joseph Valeri
Phone: 201-894-4283
NCT #: 05489588
Englewood Health IRB #: E-22-912
More Information (clinicaltrials.gov)

Extracorporeal Flow Abolition in Relation with Primary Insufficiency of Great Saphenous Veins (GSV) using High Intensity Focused Ultrasound (HIFU) Generated by Sonovein: A Multi Center Prospective Pivotal Study (VEINRESET)

Principal Investigator: Steven Elias, MD
Coordinator: Joseph Valeri
Phone: 201-894-4283
NCT #: 05926830
Englewood Health IRB #: E-23-936
More Information (clinicaltrials.gov)

VERITAS (S2473) – A Phase 4 Randomized Trial Comparing Varithena to Endothermal Ablation for the Treatment of the Great Saphenous Vein

Principal Investigator: Steven Elias, MD
Coordinator: Joseph Valeri
Phone: 201-894-4283
NCT #: 05312970
Englewood Health IRB #: E-22-895
More Information (clinicaltrials.gov)

Share This